相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Dosing will be a key success factor in repurposing antivirals for COVID-19
Patrick F. Smith et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
Bernhard Ellinger et al.
SCIENTIFIC DATA (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Ciska Verbaanderd et al.
FRONTIERS IN PHARMACOLOGY (2020)
Against pandemic research exceptionalism
Alex John London et al.
SCIENCE (2020)
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Craig R. Rayner et al.
ANTIVIRAL RESEARCH (2020)
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
Thanigaimalai Pillaiyar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
A preliminary assessment of oral monepantel's tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors
Anna Mislang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Overcoming the legal and regulatory barriers to drug repurposing
Alasdair Breckenridge et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
An update on Drug Repurposing: Re-written saga of the drug's fate
Hema G. N. S. Sree et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide
William A. Banks et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Moxidectin for deworming: from trials to implementation
Mathieu Maheu-Giroux et al.
LANCET INFECTIOUS DISEASES (2018)
Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis
Elizabeth A. Mills et al.
FRONTIERS IN NEUROLOGY (2018)
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing
Janis C. Weeks et al.
SCIENTIFIC REPORTS (2018)
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
Jeff Janes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
Drug repurposing from the perspective of pharmaceutical companies
Y. Cha et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The Essential Medicinal Chemistry of Curcumin
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
A standard database for drug repositioning
Adam S. Brown et al.
SCIENTIFIC DATA (2017)
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
J. Javier Hernandez et al.
FRONTIERS IN ONCOLOGY (2017)
Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents
Ciska Verbaanderd et al.
ECANCERMEDICALSCIENCE (2017)
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Ralf A. Linker et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2016)
Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
Y-Y Hsieh et al.
CELL DEATH DISCOVERY (2016)
Recent trends in specialty pharma business model
Mannching Sherry Ku
JOURNAL OF FOOD AND DRUG ANALYSIS (2015)
An Aggregation Advisor for Ligand Discovery
John J. Irwin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2015)
Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent
Vidula Sukhatme et al.
ECANCERMEDICALSCIENCE (2015)
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
An M. T. van Nuffel et al.
ECANCERMEDICALSCIENCE (2015)
Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function
Helgi I. Ingolfsson et al.
ACS CHEMICAL BIOLOGY (2014)
New Drug Designations for New Therapeutic Entities: New Active Substance, New Chemical Entity, New Biological Entity, New Molecular Entity
Sarah K. Branch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Functional Module Connectivity Map (FMCM): A Framework for Searching Repurposed Drug Compounds for Systems Treatment of Cancer and an Application to Colorectal Adenocarcinoma
Feng-Hsiang Chung et al.
PLOS ONE (2014)
Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
Bin Li et al.
PLOS ONE (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
A Cell-Free Fluorometric High-Throughput Screen for Inhibitors of Rtt109-Catalyzed Histone Acetylation
Jayme L. Dahlin et al.
PLOS ONE (2013)
A safe lithium mimetic for bipolar disorder
Nisha Singh et al.
NATURE COMMUNICATIONS (2013)
High-Throughput Identification of Promiscuous Inhibitors from Screening Libraries with the Use of a Thiol-Containing Fluorescent Probe
Megan M. McCallum et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
Faraz Kazmi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Joel T. Dudley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Drug repurposing and adverse event prediction using high-throughput literature analysis
Spyros N. Deftereos et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2011)
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
Waqas Rehman et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2011)
Challenges in the Search for Drugs to Treat Central Nervous System Disorders
S. J. Enna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Toxicological evaluation of thiol-reactive compounds identified using-a La assay to detect reactive molecules by nuclear magnetic resonance
Jeffrey R. Huth et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Long-term administration of mifepristone (RU486): Clinical tolerance during extended treatment of meningioma
Steven M. Grunberg et al.
CANCER INVESTIGATION (2006)
A clinical drug library screen identifies astemizole as an antimalarial agent
Curtis R. Chong et al.
NATURE CHEMICAL BIOLOGY (2006)
The major role of clinicians in the discovery of off-label drug therapies
HJ DeMonaco et al.
PHARMACOTHERAPY (2006)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Hydroxychloroquine overdose: A prospective case series
GK Isbister et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2002)
Development of a virtual screening method for identification of frequent hitters in compound libraries
O Roche et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
D Orlic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Thalomid (R) (Thalidomide) capsules - A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing
TE Clark et al.
DRUG SAFETY (2001)
Concentrations of chloroquine and malaria parasites in blood in Nigerian children
FP Mockenhaupt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
